(4E)-4-(Hydroxyimino)-2-methyl-1(4H)-quinolinol

Names

[ CAS No. ]:
10482-16-3

[ Name ]:
(4E)-4-(Hydroxyimino)-2-methyl-1(4H)-quinolinol

[Synonym ]:
4-Hydroxy-2-methyl-benzylalkohol
4-hydroxy-2-methyl-benzyl alcohol
4-Oxy-2-methyl-1-oxymethyl-benzol
2-methyl-4-hydroxybenzyl alcohol
2-Methyl-4-hydroxylamino-chinolin-1-oxid
Benzenemethanol,4-hydroxy-2-methyl
3-methyl-4-hydroxymethylphenol
4-hydroxymethyl-3-methylphenol

Chemical & Physical Properties

[ Density]:
1.3g/cm3

[ Boiling Point ]:
346.3ºC at 760mmHg

[ Molecular Formula ]:
C10H10N2O2

[ Molecular Weight ]:
190.19900

[ Flash Point ]:
163.2ºC

[ Exact Mass ]:
190.07400

[ PSA ]:
57.75000

[ LogP ]:
1.47690

[ Vapour Pressure ]:
0mmHg at 25°C

[ Index of Refraction ]:
1.633

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
VC0700000
CHEMICAL NAME :
Quinoline, 2-methyl-4-hydroxylamino-, 1-oxide
CAS REGISTRY NUMBER :
10482-16-3
BEILSTEIN REFERENCE NO. :
0475692
LAST UPDATED :
199612
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C10-H10-N2-O2
MOLECULAR WEIGHT :
190.22
WISWESSER LINE NOTATION :
T66 BNJ BO C1 EMQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
120 mg/kg/50D-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - tumors at site of application
REFERENCE :
BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year: 16,631,1967

Safety Information

[ HS Code ]:
2933499090

Customs

[ HS Code ]: 2933499090

[ Summary ]:
2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Related Compounds

  • (E)-4-(hydroxyimino)-2-methyl-1,4-dihydro-3(2H)-isoquinolinone
  • (NZ)-N-(5-chloro-1-hydroxy-quinolin-4-ylidene)hydroxylamine
  • (E)-1-phenyl-4-(hydroxyimino)-2-methyl-1,4-dihydro-3(2H)-isoquinolinone
  • 4-hydroxyimino-2-methyl-1-phenyl-1H-isoquinolin-3-one
  • (4E)-4-(Hydroxyimino)-3-methyl-1(4H)-pyridinol
  • (4E)-4-(2-FURYLMETHYLENE)-2-METHYL-1,3-OXAZOL-5(4H)-ONE
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • (3-endo)-8-Azabicyclo[3.2.1]oct-3-yl 3-methylbutanoate
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide